Ju Jihyeung, Lu Gang, Lambert Joshua D, Yang Chung S
Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA.
Semin Cancer Biol. 2007 Oct;17(5):395-402. doi: 10.1016/j.semcancer.2007.06.013. Epub 2007 Jul 4.
The possible cancer preventive activity of tea has received much attention in recent years. The inhibitory activities of tea and tea constituents against carcinogenesis at different organ sites have been demonstrated in many animal models. The effect of tea consumption on human cancers, however, remains inconclusive. The mechanisms of action of tea polyphenols, especially EGCG, the most abundant and active catechin, have been extensively investigated. Most of the studies, however, were based on cell culture systems, and these mechanisms need to be evaluated and verified in animal models or humans in order to gain more understanding on the effect of tea consumption on human cancer. Human intervention trials are warranted to determine the possible prevention of cancer of specific sites by preparation of tea constituents.
近年来,茶可能具有的防癌活性备受关注。在许多动物模型中已证实茶及其成分对不同器官部位致癌作用的抑制活性。然而,饮茶对人类癌症的影响仍无定论。茶多酚,尤其是表没食子儿茶素没食子酸酯(EGCG,含量最丰富且活性最强的儿茶素)的作用机制已得到广泛研究。然而,大多数研究基于细胞培养系统,这些机制需要在动物模型或人体中进行评估和验证,以便更深入了解饮茶对人类癌症的影响。有必要开展人体干预试验,以确定茶成分制剂对特定部位癌症的可能预防作用。